Participant flow

Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004) · Source last updated 2019-11-21

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Young adult women 16- to 26-years old received V503 vaccination, 0.5 mL in a 3-dose regimen administered on Day 1, Month 2, and Month 6.

   id

   FG000

   title

   Women 16-26 Years of Age

2. description

   Adult women 27- to 45-years old received V503 vaccination, 0.5 mL in a 3-dose regimen administered on Day 1, Month 2, and Month 6.

   id

   FG001

   title

   Women 27-45 Years of Age

periods

1. drop Withdraws

   1. reasons

      1. group Id

         FG000

         num Subjects

         0

      2. group Id

         FG001

         num Subjects

         1

      type

      Screen Failure

   2. reasons

      1. group Id

         FG000

         num Subjects

         8

      2. group Id

         FG001

         num Subjects

         9

      type

      Withdrawal by Subject

   3. reasons

      1. group Id

         FG000

         num Subjects

         0

      2. group Id

         FG001

         num Subjects

         1

      type

      Status unknown

   4. reasons

      1. group Id

         FG000

         num Subjects

         8

      2. group Id

         FG001

         num Subjects

         5

      type

      Lost to Follow-up

   5. reasons

      1. group Id

         FG000

         num Subjects

         1

      2. group Id

         FG001

         num Subjects

         0

      type

      Physician Decision

   milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         570

      2. group Id

         FG001

         num Subjects

         642

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         570

      2. group Id

         FG001

         num Subjects

         640

      type

      Vaccination 1

   3. achievements

      1. group Id

         FG000

         num Subjects

         563

      2. group Id

         FG001

         num Subjects

         635

      type

      Vaccination 2

   4. achievements

      1. group Id

         FG000

         num Subjects

         556

      2. group Id

         FG001

         num Subjects

         629

      type

      Vaccination 3

   5. achievements

      1. group Id

         FG000

         num Subjects

         553

      2. group Id

         FG001

         num Subjects

         626

      type

      COMPLETED

   6. achievements

      1. group Id

         FG000

         num Subjects

         17

      2. group Id

         FG001

         num Subjects

         16

      type

      NOT COMPLETED

   title

   Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice